Researchers have discovered that immune cells packed with lipid droplets accumulate in the brains of patients with severe multiple sclerosis and appear to drive ongoing inflammation and tissue damage. The findings suggest that targeting immune cell lipid metabolism could represent a new therapeutic avenue for slowing MS progression. — Photo by National Institute of Allergy and Infectious Diseases on Unsplash (Unsplash License)
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
